15 drug(s) with this reaction
70,439 total reports
Off Label Use has been reported as an adverse reaction across 15 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 70,439 adverse event reports mention off label use in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with off label use, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have off label use listed in their FDA adverse event reports, sorted by report count:
In addition to off label use, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
15 drug(s) manufactured by Abbvie Inc have off label use listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, VENETOCLAX, DIVALPROEX SODIUM, and others.
There are a combined 70,439 reports of off label use across 15 Abbvie Inc drug(s) in the FDA adverse event database.